T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Aehr Test Systems
AEHR
$4.02B
| $518K | ﹤0.01% |
+12,541
| New | +$411K |
|
2102
Adtran
ADTN
$665M
| $516K | ﹤0.01% |
48,914
+1,203
| +3% | +$11.9K |
|
2103
WisdomTree
WT
$3.44B
| $513K | ﹤0.01% |
74,642
+1,705
| +2% | +$11.4K |
|
|
TRTX
2104
TPG RE Finance Trust
TRTX
$610M
| $512K | ﹤0.01% |
68,971
+1,120
| +2% | +$7.58K |
|
2105
Standard Motor Products
SMP
$877M
| $511K | ﹤0.01% |
13,597
+2,021
| +17% | +$73.7K |
|
2106
Enova International
ENVA
$6.48B
| $510K | ﹤0.01% |
9,599
+335
| +4% | +$15.8K |
|
2107
Live Oak Bancshares
LOB
$1.98B
| $509K | ﹤0.01% |
19,315
+563
| +3% | +$13.3K |
|
|
KAMN
2108
DELISTED
Kaman Corp
KAMN
| $509K | ﹤0.01% |
20,881
+452
| +2% | +$10.2K |
|
2109
Aclaris Therapeutics
ACRS
$860M
| $508K | ﹤0.01% |
48,980
+1,512
| +3% | +$13.7K |
|
2110
MVB Financial
MVBF
$397M
| $508K | ﹤0.01% |
24,079
+1,525
| +7% | +$28.7K |
|
2111
First Financial Corp
THFF
$970M
| $508K | ﹤0.01% |
15,623
+1,098
| +8% | +$37.5K |
|
|
UHT
2112
Universal Health Realty Income Trust
UHT
$573M
| $507K | ﹤0.01% |
10,637
+4,974
| +88% | +$229K |
|
2113
Ubiquiti
UI
$35B
| $507K | ﹤0.01% |
2,881
-2
| -0.1% | -$404 |
|
2114
BlueLinx
BXC
$701M
| $506K | ﹤0.01% |
5,387
+155
| +3% | +$12.4K |
|
2115
Commercial Vehicle Group
CVGI
$128M
| $506K | ﹤0.01% |
45,520
+3,920
| +9% | +$35.6K |
|
2116
Health Catalyst
HCAT
$132M
| $506K | ﹤0.01% |
40,433
+676
| +2% | +$8.05K |
|
2117
Roivant Sciences
ROIV
$26.2B
| $506K | ﹤0.01% |
+50,128
| New | +$448K |
|
2118
Sabre
SABR
$831M
| $506K | ﹤0.01% |
158,396
+3,460
| +2% | +$12.5K |
|
2119
Scorpio Tankers
STNG
$3.81B
| $505K | ﹤0.01% |
10,672
+1,647
| +18% | +$81.4K |
|
|
ONIT
2120
Onity Group
ONIT
$321M
| $505K | ﹤0.01% |
16,848
+1,305
| +8% | +$37.4K |
|
2121
Columbus McKinnon
CMCO
$550M
| $504K | ﹤0.01% |
12,386
+413
| +3% | +$15.3K |
|
|
AVDX
2122
DELISTED
AvidXchange
AVDX
| $502K | ﹤0.01% |
48,310
+19,992
| +71% | +$180K |
|
|
SNBR
2123
DELISTED
Sleep Number
SNBR
| $502K | ﹤0.01% |
18,386
+1,301
| +8% | +$29.7K |
|
2124
AMERISAFE
AMSF
$517M
| $501K | ﹤0.01% |
9,385
+1,973
| +27% | +$105K |
|
2125
Rocket Companies
RKT
$42.6B
| $501K | ﹤0.01% |
55,829
+1,116
| +2% | +$9.71K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.